Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2024/25 group results

May 13 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT     
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026      YEAR       
                 LATEST         YEAR-AGO        COMPANY        COMPANY    
                 RESULTS         RESULTS       FORECAST      H1 FORECAST  
  Sales           45.04           43.51          52.50          21.30     
               (+3.5 pct)      (-44.3 pct)    (+16.6 pct)    (+7.8 pct)   
  Operating        2.26            3.00           2.50        loss 1.45   
               (-24.6 pct)     (-85.4 pct)    (+10.5 pct)                 
  Recurring        2.59            3.41           2.50        loss 1.43   
               (-23.9 pct)     (-83.5 pct)    (-3.6 pct)                  
  Net
  Net              1.04            1.48           1.30        loss 1.32   
               (-29.6 pct)     (-90.8 pct)    (+24.8 pct)                 
  EPS           8.65 yen        12.30 yen      10.08 yen   loss 10.96 yen 
  Ann Div       17.00 yen       17.00 yen      17.00 yen                  
  -Q2 Div          NIL             NIL            NIL                     
  -Q4 Div       17.00 yen       17.00 yen      17.00 yen                  
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news